Sector pending / Home Health Care ServicesUpdated 2026-05-10 22:07 UTC

FRA/CXM stock hub

FRA/CXM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/CXMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.8B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/CXM

In the news

Latest news · FRA/CXM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.6

P25 n/aP50 n/aP75 n/a

Trailing P/E21.1

P25 n/aP50 n/aP75 n/a

ROE25.6

P25 n/aP50 n/aP75 n/a

ROIC23.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/CXM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	15,811
Employees Change	116%
Employees Change Percent	0.74
Enterprise value	EUR 5B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Home Health Care Services
Last refreshed	2026-05-10
Market cap	EUR 4.8B
Price	EUR 360
Price currency	EUR
Rev Per Employee	139,359.77x
Sic	8082
Symbol	fra/CXM
Website	https://www.chemed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.73%
EV Earnings	21.98x
EV/EBIT	17.47x
EV/EBITDA	12.57x
EV/FCF	15.14x
EV/Sales	2.29x
FCF yield	6.86%
Forward P/E	16.65x
P/B ratio	6.48x
P/E ratio	21.15x
P/S ratio	2.16x
PE Ratio10 Y	28.64x
PE Ratio3 Y	28.09x
PE Ratio5 Y	27.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.13%
EBITDA Margin	15.55%
FCF margin	14.84%
Gross margin	32.38%
Gross Profit	EUR 713.4M
Gross Profit Growth	-5.09%
Gross Profit Growth Q	-0.3%
Gross Profit Growth3 Y	2.65%
Gross Profit Growth5 Y	2.58%
Net Income	EUR 225.3M
Net Income Growth	-15.86%
Net Income Growth Q	-7.6%
Net Income Growth3 Y	2.74%
Net Income Growth5 Y	-4.61%
Pretax Margin	13.73%
Profit Margin	10.23%
Profit Per Employee	EUR 14,250
ROA	12.79
Roa5y	14.44
ROCE	27.48
ROE	25.6
Roe5y	30.27
ROIC	23.47
Roic5y	27.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.76%
Cagr15y	14.96%
Cagr1y	-27.66%
Cagr20y	11.83%
Cagr3y	-9.18%
Cagr5y	-1.45%
Div CAGR10	8.77%
Div CAGR3	11.24%
Div CAGR5	11.61%
EPS Growth	-10.85
EPS Growth Q	-0.41
EPS Growth3 Y	4.82
EPS Growth5 Y	-1.89
FCF Growth	19.7%
FCF Growth Q	265.31%
FCF Growth3 Y	22.02%
FCF Growth5 Y	-3.47%
OCF Growth	21.34%
OCF Growth Q	169.42%
OCF Growth10 Y	10.31%
OCF Growth3 Y	18.12%
OCF Growth5 Y	-2.62%
Revenue Growth	2.07x
Revenue Growth Q	1.63x
Revenue Growth3 Y	5.48x
Revenue Growth5 Y	3.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.56
Assets	EUR 1.3B
Cash	EUR 14.6M
Current Assets	EUR 232.4M
Current Liabilities	EUR 272.5M
Debt	EUR 205.5M
Debt EBITDA	EUR 0.51
Debt Equity	EUR 0.28
Debt FCF	EUR 0.63
Equity	EUR 735.5M
Interest Coverage	172.6
Liabilities	EUR 596.5M
Long Term Assets	EUR 1.1B
Long Term Liabilities	EUR 324M
Net Cash	EUR -190.9M
Net Cash By Market Cap	EUR -4.01
Net Debt EBITDA	EUR 0.56
Net Debt Equity	EUR 0.26
Net Debt FCF	EUR 0.58
Tangible Book Value	EUR 69.4M
Tangible Book Value Per Share	EUR 5.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.85
Inventory Turnover	229.1
Net Working Capital	EUR -19.9M
Quick ratio	0.72
Working Capital	EUR -41.1M
Working Capital Turnover	EUR 26.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.66%
Dividend Growth	11.4%
Dividend Growth Years	17%
Dividend per share	EUR 1.98
Dividend Years	24
Dividend Yield	0.55%
Ex Div Date	2026-02-23
Last Dividend	EUR 0.51
Payout Frequency	Quarterly
Payout Ratio	12.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	232.21%
1Y total return	-27.65%
200-day SMA	366.9
3Y total return	-25.09%
50-day SMA	339
50-day SMA vs 200-day SMA	50under200
5Y total return	-7.03%
All Time High	605
All Time High Change	-40.5%
All Time High Date	2024-03-19
All Time Low	15.38
All Time Low Change	2,240.55%
All Time Low Date	2004-07-26
ATR	5.14
Ch YTD	-1.64
High	360
High52	515
High52 Date	2025-05-19
High52ch	-30.1%
Low	360
Low52	316
Low52 Date	2026-04-23
Low52ch	13.92%
Ma50ch	6.19%
Price vs 200-day SMA	-1.88%
RSI	61.45
RSI Monthly	38.36
RSI Weekly	48.95
Sharpe ratio	-0.95x
Sortino ratio	-1.03
Total Return	6.21%
Tr YTD	-1.51
Tr15y	709.54%
Tr1m	8.43%
Tr1w	1.12%
Tr3m	-5.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 289.4M
Operating Income Growth	-14.29
Operating Income Growth Q	-10.74
Operating Income Growth3 Y	0.31
Operating Income Growth5 Y	1.12
Operating margin	13.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,992,879%
Net Borrowing	85,846,824.9
Shares Insiders	1.61%
Shares Institutions	104.69%
Shares Qo Q	-2.28%
Shares Yo Y	-5.66%
Short Ratio	1.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 294.3M
Average Volume	1.55x
Bv Per Share	55.64
CAPEX	EUR -57.8M
Ch10y	219.5
Ch15y	642.7
Ch1m	8.43
Ch1w	1.12
Ch1y	-28
Ch20y	729.5
Ch3m	-5.26
Ch3y	-25.93
Ch5y	-8.63
Ch6m	-2.7
Change	0.56%
Change From Open	0
Close	358
Days Gap	0.56
Depreciation Amortization	52,062,322.9
Earnings Date	2026-04-23
EBIT	EUR 289.4M
EBITDA	EUR 342.6M
EPS	EUR 15.87
F Score	5
FCF	EUR 327.1M
FCF EV Yield	6.6x
Financing CF	-448,669,901
Fiscal Year End	December
Founded	1,970
Goodwill	582,974,723
Graham Number	145.88415
Graham Upside	-59.48
Income Tax	EUR 77.3M
Investing CF	-72,380,522
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	2005-05-12
Last Split Type	Forward
Lynch Fair Value	EUR 85.11
Lynch Upside	-76.36
Ma150	362.2
Ma150ch	-0.6%
Ma20	340.4
Ma20ch	5.76%
Net CF	-136,188,650
Next Earnings Date	2026-07-29
Open	360
P FCF Ratio	14.57
P OCF Ratio	12.38
Payment Date	2026-03-13
Ppne	289,435,717.4
Price Date	2026-05-08
Price EBITDA	EUR 13.91
Ptbv Ratio	68.61
Relative Volume	16.77x
Revenue	2,203,417,280x
SBC By Revenue	1.49x
Share Based Comp	32,787,409
Tax By Revenue	3.51x
Tax Rate	25.55%
Tr20y	835.83%
Tr6m	-2.45%
Z Score	10.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/CXM dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$1.98 annual per share

Payout ratio

+12.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.6%

17 consecutive years of growth

Total shareholder yield

+6.2%

Next ex-dividend date: 2026-02-23

Performance

FRA/CXM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/CXM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+104.7%

Share of float held by funds and institutions

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/CXM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.5

Neutral momentum band

Price vs 200-day MA

-1.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/CXM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/CXM stock rating?

fra/CXM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/CXM analysis?

The full report lives at /stocks/fra/CXM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/CXM?

The latest report frames fra/CXM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/CXM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.